Microrna363-5p targets thrombospondin3 to regulate pathological cardiac remodeling
- PMID: 39373825
- DOI: 10.1007/s11010-024-05125-7
Microrna363-5p targets thrombospondin3 to regulate pathological cardiac remodeling
Abstract
Cardiac remodeling is an end-stage manifestation of multiple cardiovascular diseases, and microRNAs are involved in a variety of posttranscriptional regulatory processes. miR-363-5p targeting Thrombospondin3 (THBS3) has been shown to play an important regulatory role in vascular endothelial cells, but the roles of these two in cardiac remodeling are unknown. Firstly, we established an in vivo model of cardiac remodeling by transverse aortic narrow (TAC), and then we stimulated a human cardiomyocyte cell line (AC16) and a human cardiac fibroblast cell line (HCF) using 1 μmol/L angiotensin II (Ang II) to establish an in vitro model of cardiac hypertrophy and an in vitro model of myocardial fibrosis, respectively. In all three of the above models, we found a significant decreasing trend of miR-363-5p, suggesting that it plays a key regulatory role in the occurrence and development of cardiac remodeling. Subsequently, overexpression of miR-363-5p significantly attenuated myocardial hypertrophy and myocardial fibrosis in vitro as evidenced by reduced the area of AC16, the cell viability of HCFs, the relative expression of the protein of fetal genes (ANP, BNP, β-MHC) and fibrosis marker (collagen I, collagen III, α-SMA), whereas inhibition of miR-363-5p expression showed the opposite trend. In addition, we also confirmed the targeted binding relationship between miR-363-5p and THBS3 by dual luciferase reporter gene assay, and the expression of THBS3 was directly inhibited by miR-363-5p. Moreover, overexpression of miR-363-5p with THBS3 simultaneously partially eliminated the delaying effect of miR-363-5p on myocardial hypertrophy and myocardial fibrosis in vitro. In conclusion, Overexpression of miR-363-5p attenuated the prohypertrophic and profibrotic effects of Ang II on AC16 and HCF by a mechanism related to the inhibition of THBS3 expression.
Keywords: Cardiac hypertrophy; Cardiac remodeling; MicroRNA-363-5p; Myocardial fibrosis; Thrombospondin 3.
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Declarations. Conflicts of interest: The authors declare no competing interests. Ethical approval: All procedures involving animals were conformed to the National Institutes of Health Guide for the Care and Use of Laboratory Animals and approved (IACUC-BNT-2023-010) by the Experimental Animal Ethics Committee of BEIENTE Biotechnology Co., Ltd, HuBei, China (SYSK-2021-0119).
References
-
- Jeong A, Lim Y, Kook T, Kwon DH, Cho YK, Ryu J, Lee YG, Shin S, Choe N, Kim YS, Cho HJ, Kim JC, Choi Y, Lee SJ, Kim HS, Kee HJ, Nam KI, Ahn Y, Jeong MH, Park WJ, Kim YK, Kook H (2023) Circular RNA circSMAD4 regulates cardiac fibrosis by targeting miR-671-5p and FGFR2 in cardiac fibroblasts. Mol Ther Nucleic Acids 34:1–19. https://doi.org/10.1016/j.omtn.2023.102071 - DOI
-
- Li J, Salvador AM, Li G, Valkov N, Ziegler O, Yeri A et al (2021) Mir-30d regulates cardiac remodeling by intracellular and paracrine signaling. Circ Res. https://doi.org/10.1161/circresaha.120.317244 - DOI - PMC
-
- Ambrosy AP, Fonarow GC, Butler J, Chioncel O, Greene SJ, Vaduganathan M et al (2014) The global health and economic burden of hospitalizations for heart failure. J Am Coll Cardiol 63(12):1123–1133. https://doi.org/10.1016/j.jacc.2013.11.053 - DOI
-
- Li G, Shao Y, Guo HC, Zhi Y, Qiao B, Ma K et al (2022) MicroRNA-27b-3p down-regulates FGF1 and aggravates pathological cardiac remodelling. Cardiovasc Res 118(9):2139–2151. https://doi.org/10.1093/cvr/cvab248 - DOI
-
- Zhao L, Qi F, Du D, Wu N (2022) Histone demethylase KDM3C regulates the lncRNA GAS5–miR-495-3p–PHF8 axis in cardiac hypertrophy. Ann N Y Acad Sci 1516:286–299. https://doi.org/10.1111/nyas.14813 - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous